OKYO Pharma Ownership 2024 | Who Owns OKYO Pharma Now?
Institutional Ownership
0.13%
Insider Ownership
27.61%
Retail Ownership
72.26%
Institutional Holders
1.00
OKYO Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GOLDMAN SACHS GROUP INC | - | - | - | -19,807 | -100.00% | - | Jun 30, 2023 |
OKYO Pharma's largest institutional shareholder is GOLDMAN SACHS GROUP INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GOLDMAN SACHS GROUP INC | - | - | - | -19,807 | -100.00% | - | Jun 30, 2023 |
The largest OKYO Pharma shareholder by % of total assets is GOLDMAN SACHS GROUP INC. The company owns 0.00 shares of OKYO Pharma (OKYO), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GOLDMAN SACHS GROUP INC | - | - | - | -19,807 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, OKYO Pharma's largest institutional buyer is GOLDMAN SACHS GROUP INC. The company purchased -19.81K stocks of OKYO, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GOLDMAN SACHS GROUP INC | - | - | - | -19,807 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, OKYO Pharma's biggest institutional seller is GOLDMAN SACHS GROUP INC. The company sold -19.81K shares of OKYO, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GOLDMAN SACHS GROUP INC | - | - | - | -19,807 | -100.00% | - | Jun 30, 2023 |
OKYO Pharma's largest sold out institutional shareholder by shares sold is GOLDMAN SACHS GROUP INC, sold -19.81K shares, valued at -, as of undefined.
OKYO Pharma Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.00% | 12,090 | - | - | Feb 29, 2024 |
OKYO Pharma's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 12.09K shares, compromising 0.00% of its total assets.
OKYO Pharma Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 23 | 1 | - |
31 Dec, 22 | 1 | - |
30 Sep, 22 | 1 | -50.00% |
30 Jun, 22 | 2 | - |
As of 31 Mar 23, 1 institutions are holding OKYO Pharma's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 23 | 19,807 | 163.29% |
31 Dec, 22 | 7,523 | 536.46% |
30 Sep, 22 | 1,182 | -96.13% |
30 Jun, 22 | 30,531 | - |
OKYO Pharma (OKYO) has 19.81K shares outstanding as of 31 Mar 23, up 163.29% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 23 | 0.13% | 5276.35% |
31 Dec, 22 | 0.05% | 81597.44% |
30 Sep, 22 | 0.01% | 19.09% |
30 Jun, 22 | 0.20% | - |
As of 31 Mar 23, OKYO Pharma is held by 0.13% institutional shareholders, representing a 5276.35% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 23 | 1 | - |
31 Dec, 22 | 1 | - |
30 Sep, 22 | - | -100.00% |
30 Jun, 22 | 2 | - |
1 institutional shareholders have increased their position in OKYO stock as of 31 Mar 23 compared to 1 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 23 | - | - |
31 Dec, 22 | - | -100.00% |
30 Sep, 22 | 1 | - |
30 Jun, 22 | - | - |
- institutional shareholders have reduced their position in OKYO stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 23 | 1 | - | 19,807 | 163.29% | 0.13% | 5276.35% | 1 | - | - | - |
31 Dec, 22 | 1 | - | 7,523 | 536.46% | 0.05% | 81597.44% | 1 | - | - | -100.00% |
30 Sep, 22 | 1 | -50.00% | 1,182 | -96.13% | 0.01% | 19.09% | - | -100.00% | 1 | - |
30 Jun, 22 | 2 | - | 30,531 | - | 0.20% | - | 2 | - | - | - |
OKYO Pharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of OKYO Pharma's stock was made by Shah Keeren on May 16 2022, selling 500,000 shares at $0.06 per share (valued at $32.00K). The last insider buy of OKYO was made by BRANCACCIO JOHN P on Sep 28 2023, buying 16,670 shares at $1.50 per share (worth $25.00K).
OKYO Pharma Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2022 | 5 | 10 | 50.00% |
5 total buy trades, and 10 total sell trades (buy/sell ratio of 0.50%) were made by OKYO Pharma's insiders, as of Q2 2022.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2022 | 5 | - | - |
As of Q2 2022, Insider owners conducted 5 open market buy trades and 0 open market sell trades of OKYO Pharma's stocks.
OKYO Pharma Peer Ownership
Ticker | Company |
---|---|
SNTI | Senti Biosciences, Inc. |
MGTA | Dianthus Therapeutics, Inc. |
FHTX | Foghorn Therapeutics Inc. |
CVKD | Cadrenal Therapeutics, Inc. Common Stock |
PXMD | PaxMedica, Inc. Common Stock |
QNRX | Quoin Pharmaceuticals, Ltd. |
HILS | Tharimmune, Inc. |
CMND | Clearmind Medicine Inc. |
VRAX | Virax Biolabs Group Limited |
CADL | Candel Therapeutics, Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
UNCY | Unicycive Therapeutics, Inc. |
CDIO | Cardio Diagnostics Holdings, Inc. |
OKYO Ownership FAQ
Who Owns OKYO Pharma?
OKYO Pharma is owned by institutional shareholders (0.13%), insiders (27.61%), and public (72.26%). The largest institutional shareholder of OKYO Pharma is GOLDMAN SACHS GROUP INC (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of OKYO Pharma?
OKYO Pharma's major institutional shareholders are GOLDMAN SACHS GROUP INC. The top five shareholders own together 0% of the company's share outstanding.
How many OKYO Pharma shareholders are there?
As of Mar 2023, there are 1 institutional shareholders of OKYO Pharma.
What percentage of OKYO Pharma is owned by GOLDMAN SACHS GROUP INC?
GOLDMAN SACHS GROUP INC owns 0 shares of OKYO Pharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).